Product Information
DESVENLAFAXINE SUCCNT ER 25 MG is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.3985 per EA under NDC 51991000633. Its NADAC has been published 407 times since Dec 19, 2018.
FDA first approved this application on Jun 29, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991000633
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESVENLAFAXINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204003FDA Approved
6/29/2015
TE Code
AB
On Market Since
11/28/2018
Pharmacological Classes
Price Statistics
The NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has been published 407 times since Dec 19, 2018, and over the history we have for it it has declined 48.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3985 per EA |
|---|---|
| All-time high | $0.8952 (May 15, 2019) |
| All-time low | $0.3565 (Nov 20, 2024) |
| 52-week high | $0.4592 |
| 52-week low | $0.3985 |
| Median price | $0.5534 |
| Average price | $0.6135 |
| Largest weekly change | +36.5% (Aug 21, 2024) |
| Weeks tracked | 407 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Breckenridge Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desvenlafaxine Succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESVENLAFAXINE SUCCNT ER 25 MG?
The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE SUCCNT ER 25 MG, manufactured by Breckenridge Pharmaceutical Inc., is $0.3985 per EA (NDC 51991000633), effective Sep 30, 2026.
How has the price of DESVENLAFAXINE SUCCNT ER 25 MG changed over time?
Over the history we have for it, the NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has declined 48.2%. It has been tracked across 407 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE SUCCNT ER 25 MG?
Since Dec 19, 2018, the NADAC for DESVENLAFAXINE SUCCNT ER 25 MG has ranged from a low of $0.3565 (Nov 20, 2024) to a high of $0.8952 (May 15, 2019), with a median of $0.5534 per EA.
Are there cheaper alternatives to DESVENLAFAXINE SUCCNT ER 25 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESVENLAFAXINE SUCCNT ER 25 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures DESVENLAFAXINE SUCCNT ER 25 MG?
DESVENLAFAXINE SUCCNT ER 25 MG (NDC 51991000633) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.